A closer look at Johnson & Johnson's COVID-19 vaccine

The vaccine has an efficacy of 66% worldwide
Author: Jade Cunningham / WWL Eyewitness News
Published: 6:02 PM CST January 29, 2021
Updated: 6:06 PM CST January 29, 2021
NEW ORLEANS — It's possible a third COVID-19 vaccine could be approved soon. 
Johnson & Johnson released the findings from their trial Friday and are expected to request emergency approval by the FDA in about a week.
Requiring only one dose and regular refrigeration, Johnson & Johnson's COVID-19 vaccine is being called a "gamechanger."
"The fact that we have another vaccine that looks very good, that is only a single dose, is going to help immunize a lot more people a lot faster," said Tulane Microbiologist, Lisa Morici, PhD.

Related Keywords

United States , South Africa , Lisa Morici , Johnson , Pfizer , Tulane Microbiologist , New Orleans , ஒன்றுபட்டது மாநிலங்களில் , லிசா மோரீசி , ஜான்சன் , ஃபைசர் , துலேன் நுண்ணுயிரியலாளர் , புதியது ஆர்லீயந்ஸ் ,